ArticleFrontiers in human neuroscience2025
Association of deep tiny flow voids with prognosis of acute middle cerebral artery atherosclerotic occlusion.
Article in Frontiers in human neuroscience, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Deep tiny flow voids (DTFVs) have recently been identified as a novel form of collateral circulation linked to chronic steno-occlusive atherosclerotic middle cerebral artery (MCA) lesions, detectable via high-resolution magnetic resonance imaging (HR-MRI). To date, no study has focused on the presence and clinical significance of DTFVs in acute MCA atherosclerotic occlusion. Materials and methods: This retrospective study included patients with acute MCA atherosclerotic occlusion from two multicenter HR-MRI cohorts. The incidence of DTFVs and its association with baseline National Institute of Health Stroke Scale (NIHSS) scores, infarct volume, and the proportion of patients with a favorable 90-day clinical outcome defined as a modified Rankin Scale (mRS) ≤ 2 were analyzed. Results: Sixty-six patients (mean age 58.2 ± 9.2 years; 71.2% men) were included. The median time from stroke onset to image was 44.5 (27.3-67.0) hours. DTFVs were identified in 57.6% of patients with MCA atherosclerotic occlusion. After adjusting the potential confounders, DTFVs were significantly associated with lower baseline NIHSS scores (β, -3.68; 95% CI, -6.30, -1.07; Conclusion: The presence of DTFVs was correlated with a favorable outcome in patients with acute MCA atherosclerotic occlusion. Improved recognition and awareness of this imaging marker of collaterals could help understand the varying infarct evolution seen in MCA occlusion and contribute to more individualized management and treatment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.